Checkpoint Capital L.P. TCRX Holdings History
Checkpoint Capital L.P.'s TScan Therapeutics Inc Holding Summary
As of 2025-03-31, Checkpoint Capital L.P. held 2.02 Mil shares of TScan Therapeutics Inc(TCRX), totaling $2.78 Mil. This investment constitutes 1.53% of their stock portfolio, and Checkpoint Capital L.P. now holds 3.57% of the outstanding TScan Therapeutics Inc(TCRX) stock.
The initial trade took place in 2024Q3. And since then Checkpoint Capital L.P. has made 3 purchases of TCRX, at an average price of $4.84, for a total of 2.02 Mil shares. Based on historical transaction data and TCRX's current price of $1.47, Checkpoint Capital L.P.'s estimated gain on his TCRX holdings is $-6.79 Mil, reflecting a -69.60% gain to date.
Checkpoint Capital L.P. TCRX ($1.47) Holding Chart
Checkpoint Capital L.P. TCRX ($1.47) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
